Patients with rheumatoid arthritis (RA) and other inflammatory joint disorders (IJD) have
increased cardiovascular disease (CVD) risk compared with the general population. In …

Rheumatoid arthritis is a systemic autoimmune disease characterized by excess morbidity
and mortality from cardiovascular disease. Mechanisms linking rheumatoid arthritis and …

Introduction The aim of this work is to evaluate baricitinib safety with respect to venous
thromboembolism (VTE), major adverse cardiovascular events (MACE), and serious …

Abstract An Expert Panel convened by the National Lipid Association previously developed
a consensus set of recommendations for the patient-centered management of dyslipidemia …

Background Patients with rheumatoid arthritis (RA) are at increased risk of developing
comorbid conditions. Objectives To evaluate the prevalence of comorbidities and compare …

Executive summary Despite the improvements in outcomes for cardiovascular disease
(CVD) over the last 20 years, it remains the major cause of morbidity and mortality in the …

Objectives Patients with rheumatoid arthritis (RA) have an excess risk of cardiovascular
disease (CVD). We aimed to assess the impact of CVD risk factors, including potential sex …

Objective To characterize the hospitalization and death rates among patients with
inflammatory arthritis (IA) affected by coronavirus disease 2019 (COVID‐19) and to analyze …

Objective Use of several immunomodulatory agents has been associated with reduced
numbers of cardiovascular (CV) events in epidemiologic studies of rheumatoid arthritis (RA) …

Objective A systematic literature review (SLR; 2009–2014) to compare a target-oriented
approach with routine management in the treatment of rheumatoid arthritis (RA) to allow an …